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Abstract
Background: Hepatocellular carcinoma has a poor prognosis; few patients can undergo surgical curative treatment
according to Barcelona Clinic Liver Cancer guidelines. Progress in surgical techniques has led to operations for more
patients outside these guidelines. Our case shows a patient with intermediate stage hepatocellular carcinoma presenting
a good outcome after curative treatment.
Case presentation: We report the case of an 80-year-old Moroccan man, who was positive for hepatitis c
virus, presenting an intermediate stage hepatocellular carcinoma (three lesions between 20 and 60 mm). He
presented a complete tumor necrosis after portal vein embolization and achieved 24-month disease-free
survival after surgery.
Conclusions: Perioperative care in liver surgery and multidisciplinary discussion can help to extend indications
for liver resection for hepatocellular carcinoma outside European Association for the Study of the Liver/American
Association for the Study of Liver Diseases recommendations and offer a curative approach to selected patients with
intermediate and advanced stage hepatocellular carcinoma.
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Background
Less than one out of three patients diagnosed with hepa-
tocellular carcinoma (HCC) may undergo a curative
treatment: liver resection, liver transplantation, or percu-
taneous ablation [1]. Refinement of surgical techniques
and perioperative care helped to extend indications for
liver resection for HCC outside European Association
for the Study of the Liver (EASL)/American Association
for the Study of Liver Diseases (AASLD) recommenda-
tions with encouraging short-term and long-term out-
comes [2]. When a liver resection of more than three
segments is considered, preoperative portal vein
embolization (PVE) is of critical importance because it
induce a significant growth of the remnant liver, and
prevent a potentially lethal postoperative liver failure [3].
Because of a main arterial supply, HCC may respond to
transarterial embolization or transarterial chemoemboli-
zation (TACE) but not PVE. We report a case of a
complete histological necrosis of a HCC after preopera-
tive right PVE.
Case presentation
An 80-year-old Moroccan man presented with a 4-month
history of nonspecific abdominal pain and asthenia, he
had no comorbidity except late onset asthma. His
performance status was good (PS 0 to 1) and a physical
examination unremarkable. Abdominal imaging (ultra-
sound and contrast-enhanced computed tomography)
showed three liver lesions of 20 mm (liver segment 7),
27 mm (liver segment 5), and 60 mm (liver segment 6).
None of the three lesions fulfilled imaging diagnosis cri-
teria for HCC (Fig. 1; poor arterial enhancement). His
spleen size was normal and there was no sign of portal
hypertension. Laboratory tests found a slight cytolysis of
1.4-fold normal value. His serum dosage of bilirubin and
albumin, and prothrombin time were normal. His serum
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alpha-fetoprotein (AFP) value was 341.40 ng/ml (nor-
mal value <5 ng/ml). Hepatitis C virus (HCV) ser-
ology was positive for a genotype 1b virus with a viral
load of 4.36 log. Hepatitis B virus (HBV) serology was
negative. Pathology analysis of percutaneous liver and
tumor (liver segment 6) biopsy showed respectively a
chronic active hepatitis A3F2 according to METAVIR
score and a well-differentiated HCC, staging our patient
as an intermediate stage B according to the Barcelona
Clinic Liver Cancer (BCLC) algorithm. After a multidis-
ciplinary meeting, we decided his treatment should be a
right hepatectomy. Calculation of the future remnant liver
volume (FRL) by software technique found FRL (left liver
and segment 1) of 340 ml. A percutaneous portal
embolization using ipsilateral technique (embolization of
right portal vein collaterals through right liver puncture)
was performed with subsequent FRL hypertrophy: 640 ml
(+53 %) after 4 weeks. An open right hepatectomy was
performed. Specimen pathology analysis found three well-
limited nodules with necrotic-hemorrhagic remodeling with
a total tumor necrosis and lack of perennial tumor cell in
microscopy. His postoperative courses were uneventful.
He is alive and free from disease after a follow-up of
24 months.
Discussion
The effect of PVE on HCC remains controversial and is
not well established. Some authors have suggested an
anti-tumor effect of PVE on HCC related to partial tumor
necrosis after portal thrombosis [4] or total tumor necro-
sis after PVE [5]. Others suggested a pro-tumor effect of
PVE on primary tumors of the liver [6, 7] that may be ex-
plained by: (1) the compensatory augmentation of the
arterial flow to the tumor after PVE [8], (2) expression of
cytoprotective genes involved in remodeling and cell re-
pair as a response to the stress, and (3) induction and
modulation of cytokine secretion and growth factors such
as tumor necrosis factor (TNF) and hepatocyte growth
factor (HGF) [7].
Our report showed a complete histological necrosis of
a well-differentiated HCC after preoperative right PVE.
This result was unexpected because HCC have a pre-
dominant arterial vascularization [9]. Hypothesis 1: some
HCC may have predominant portal vascularization. In
our patient, this may have been the case as initial im-
aging showed poor arterial enhancement. Hypothesis 2:
a spontaneous regression may occur. Spontaneous re-
gression is defined by a complete or partial clearance of
malignant cells in the absence of all treatment or in the
presence of therapy that is considered inadequate to
exert a significant influence on the neoplastic disease.
From a physiopathology point of view, this phenomenon
may be caused by hypoxia due to rapid tumor growth,
tumor infarction following hemorrhagic shock, circula-
tory failure by arterial thrombosis or venous thrombosis,
or reactivation and recognition of tumor cells by the im-
mune system. Spontaneous regression may occur in ap-
proximately 1/100,000 patients with malignant tumor
including HCC. Only 12 pathologically proven cases of
HCC regression (including our case) have been reported
in the literature [10]. Hypothesis 3: an arterial trauma
may cause ischemia. In fact, an asymptomatic proximal
intrahepatic arterial trauma may be caused during fine
liver biopsy and/or percutaneous PVE procedure. This
last hypothesis is validated by the facts that in our pa-
tient, PVE was performed with multiple right liver (ipsi-
lateral) punctures and that complete necrosis was
recorded in all of the three lesions. In our opinion, com-
bined disruption of a predominant portal flow by PVE
(hypothesis 1) and arterial flow by a puncture trauma
may explain the result in our patient.
Complete necrosis should have been suspected while
performing a second preoperative liver imaging to assess
future liver remnant hypertrophy but it would not have
Fig. 1 Enhanced computed tomography images showing three liver lesions of 20 mm (liver segment 7), 27 mm (liver segment 5), and 60 mm
(liver segment 6)
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changed our surgical strategy. In fact, relapse of spon-
taneously necrotized HCC has been reported [11] and
viable persistence of tumoral cells has also been often
observed despite a diagnosis of advanced tumor necrosis
in imaging examinations [12].
Conclusions
Refinement of perioperative care in liver surgery, includ-
ing preoperative portal embolization and multidisciplinary
discussion, has helped to extend indications for liver re-
section for HCC outside EASL/AASLD recommendations
and offers a curative approach to selected patients with
intermediate (our patient) and advanced stage HCC.
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